From fluid restrictions to decreased activity to the use of phosphate binders, individuals with CKD are predisposed to developing constipation. Functional constipation versus more serious medical problems are reviewed. An arsenal of tools used to treat constipation and their effects are discussed. An action plan to prevent constipation is developed as well as a stepwise program to treat mild, moderate, and severe forms of constipation.
Contact hours available until 4/24/2015
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure: Planning Committee: Kristin Larson – Consultant, Nephrology Clinical Solutions; Employee, Affymax; Other financial support, Kristin M. Larson, RN, MSN, LLC; Sandy Bodin – Employee, Affymax; Dawn Koonkongsatian – Employee, Fresenius Medical Care; Elizabeth St. John - Employee, Fresenius Medical Care
Presenter(s) have no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declare.
Non-Endorsement of Products: Accreditation of activities for contact hours does not imply approval or endorsement of any product, advertising, or educational content by ANNA or the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Objectives: • Define constipation. • List two strategies for managing constipation at each stage: mild, moderate, or severe. • List two patient education goals for constipation prevention.